N-linked glycosylation of the M-protein variable region: glycoproteogenomics reveals a new layer of personalized complexity in multiple myeloma

Langerhorst, P; Baerenfaenger, M; Kulkarni, P; Nadal, S; Wijnands, C; Post, MA; Noori, S; vanDuijn, MM; Joosten, I; Dejoie, T; van Gool, AJ; Gloerich, J; Lefeber, DJ; Wessels, HJCT; Jacobs, JFM

Journal article

N-linked glycosylation of the M-protein variable region: glycoproteogenomics reveals a new layer of personalized complexity in multiple myeloma

Abstract:: Objectives: Multiple myeloma (MM) is a plasma cell malignancy characterized by a monoclonal expansion of plasma cells that secrete a characteristic M-protein. This M-protein is crucial for diagnosis and monitoring of MM in the blood of patients. Recent evidence has emerged suggesting that N-glycosylation of the M-protein variable (Fab) region contributes to M-protein pathogenicity, and that it is a risk factor for disease progression of plasma cell disorders. Current methodologies lack the specificity to provide a site-specific glycoprofile of the Fab regions of M-proteins. Here, we introduce a novel glycoproteogenomics method that allows detailed M-protein glycoprofiling by integrating patient specific Fab region sequences (genomics) with glycoprofiling by glycoproteomics. Methods: Glycoproteogenomics was used for the detailed analysis of de novo N-glycosylation sites of M-proteins. First, Genomic analysis of the M-protein variable region was used to identify de novo N-glycosylation sites. Subsequently glycopeptide analysis with LC-MS/MS was used for detailed analysis of the M-protein glycan sites. Results: Genomic analysis uncovered a more than two-fold increase in the Fab Light Chain N-glycosylation of M-proteins of patients with Multiple Myeloma compared to Fab Light Chain N-glycosylation of polyclonal antibodies from healthy individuals. Subsequent glycoproteogenomics analysis of 41 patients enrolled in the IFM 2009 clinical trial revealed that the majority of the Fab N-glycosylation sites were fully occupied with complex type glycans, distinguishable from Fc region glycans due to high levels of sialylation, fucosylation and bisecting structures. Conclusions: Together, glycoproteogenomics is a powerful tool to study de novo Fab N-glycosylation in plasma cell dyscrasias.

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Langerhorst, P., Baerenfaenger, M., Kulkarni, P., Nadal, S., Wijnands, C., Post, M. A., Noori, S., vanDuijn, M. M., Joosten, I., Dejoie, T., van Gool, A. J., Gloerich, J., Lefeber, D. J., Wessels, H. J. C. T., & Jacobs, J. F. M. (2024). N-linked glycosylation of the M-protein variable region: glycoproteogenomics reveals a new layer of personalized complexity in multiple myeloma. Clinical Chemistry and Laboratory Medicine, 62(8), 1626–1635.

MLA Style

Langerhorst, P, et al. “N-Linked Glycosylation of the M-Protein Variable Region: Glycoproteogenomics Reveals a New Layer of Personalized Complexity in Multiple Myeloma.” Clinical Chemistry and Laboratory Medicine, vol. 62, no. 8, 2024, pp. 1626–35.

Chicago Style

Langerhorst, P, M Baerenfaenger, P Kulkarni, et al. 2024. “N-Linked Glycosylation of the M-Protein Variable Region: Glycoproteogenomics Reveals a New Layer of Personalized Complexity in Multiple Myeloma.” Clinical Chemistry and Laboratory Medicine 62 (8): 1626–35.
Print